← Patent-cliff monitor small molecule INJECTAFER FERRIC CARBOXYMALTOSE
Loss of exclusivity February 2028 latest FDA-listed patent expiry
Company AMERICAN REGENT INC
Drug detail Brand name INJECTAFER Active ingredient FERRIC CARBOXYMALTOSE Strength 750MG IRON/15ML (50MG IRON/ML) Dosage form SOLUTION Route INTRAVENOUS Modality Small molecule FDA approval July 2013 Marketing status RX
Listed patents Patent Expires Type 7754702 February 2028 use U-3313 7612109 February 2027 substance, product 8895612 January 2027 use U-3316 11478502 January 2027 use U-3474 11433091 January 2027 use U-3634 11364260 January 2027 use U-3637
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.